A223
/ Sichuan Kelun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 02, 2025
Placebo-controlled trial of pharmacokinetics, pharmacodynamics and tolerability of KL130008 capsule in patients with rheumatoid arthritis.
(PubMed, Expert Opin Investig Drugs)
- P1 | "Efficacy are exploratory given the small sample size. Registered in the Chinese Clinical Trial Register (ChiCTR2000029360)."
Clinical • Journal • PK/PD data • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
August 11, 2022
A Study of KL130008 in Adults With Severe Alopecia Areata
(clinicaltrials.gov)
- P2 | N=176 | Not yet recruiting | Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
New P2 trial • Alopecia
1 to 2
Of
2
Go to page
1